Phase 2
๐ Investigational Drug / Biologic
NCT05096481
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
๐ Children's Hospital Colorado โ Aurora, Colorado
View Study & Screener โ